FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Cadila Pharmaceuticals Limited)

View source ↗

Summary

FDA approved the supplemental application for Rosuvastatin Calcium submitted by Cadila Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

SUPPL AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)